Influenza epidemiology, vaccine coverage and vaccine effectiveness in children admitted to sentinel Australian hospitals in 2014: The influenza complications alert network (FluCAN)

Eurosurveillance

Volumn 21, Issue 30, 2016, Pages

  Blyth, C C ^a,b,c   Macartney, K K ^d   Hewagama, S ^e   Senenayake, S ^f,g   Friedman, N D ^h   Simpson, G ⁱ   Upham, J ^j   Kotsimbos, T ^k   Kelly, P ^f,l   Cheng, A C ^k  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e ALICE SPRINGS HOSPITAL   (Australia)

^f The Australian National University   (Australia)

^g CANBERRA HOSPITAL   (Australia)

^h BARWON HEALTH   (Australia)

ⁱ CAIRNS BASE HOSPITAL   (Australia)

^j PRINCESS ALEXANDRA HOSPITAL   (Australia)

^k MONASH UNIVERSITY   (Australia)

^l Australia   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

INACTIVATED VACCINE; INFLUENZA VACCINE; OSELTAMIVIR;

ADOLESCENT; ANTIVIRAL THERAPY; ARTICLE; AUSTRALIA; CHILD; COMORBIDITY; COUGHING; DISEASE PREDISPOSITION; DISEASE SURVEILLANCE; DRUG EFFICACY; FEMALE; HUMAN; INFANT; INFLUENZA; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; NEWBORN; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; RHINORRHEA; RISK FACTOR; ADULT; AGED; CASE CONTROL STUDY; DISEASE NOTIFICATION; HOSPITALIZATION; IMMUNOLOGY; INFLUENZA A VIRUS (H1N1); INFLUENZA A VIRUS (H3N2); INFLUENZA, HUMAN; MIDDLE AGED; PRESCHOOL CHILD; SEASON; SENTINEL SURVEILLANCE; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; VACCINATION; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUSTRALIA; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DISEASE NOTIFICATION; FEMALE; HOSPITALIZATION; HUMANS; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; LOGISTIC MODELS; MALE; MIDDLE AGED; RISK FACTORS; SEASONS; SENTINEL SURVEILLANCE; VACCINATION; VACCINES, INACTIVATED;

EID: 85015137456     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES.2016.21.30.30301     Document Type: Article

References (27)

1. Dawood FS, Iuliano AD, Reed C, Meltzer MI, Shay DK, Cheng PY, et al. Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. Lancet Infect Dis. 2012;12(9):687-95. DOI: 10.1016/S1473-3099(12)70121-4 PMID: 22738893
2. Chiu C, Dey A, Wang H, Menzies R, Deeks S, Mahajan D, et al. Vaccine preventable diseases in Australia, 2005 to 2007. Commun Dis Intell Q Rep. 2010;34:1-167.PMID: 21416762
3. Carr S. Seasonal and pandemic influenza: an overview with pediatric focus. Adv Pediatr. 2012;59(1):75-93. DOI: 10.1016/j.yapd.2012.04.016 PMID: 22789575
4. Khandaker G, Zurynski Y, Ridley G, Buttery J, Marshall H, Richmond PC, et al. Clinical epidemiology and predictors of outcome in children hospitalised with influenza A(H1N1) pdm09 in 2009: a prospective national study. Influenza Other Respi Viruses. 2014;8(6):636-45. DOI: 10.1111/irv.12286 PMID: 25263176
5. Zurynski Y, McIntyre P, Booy R, Elliott EJ, PAEDS Investigators Group. Paediatric active enhanced disease surveillance: a new surveillance system for Australia. J Paediatr Child Health. 2013;49(7):588-94. DOI: 10.1111/jpc.12282 PMID: 23781900
6. Australian Technical Advisory Group on Immunisation. Australian Immunisation Handbook 10th Edition. Canberra: Department of Health; 2013. [Accessed Oct 2015]. Available from: http://www.immunise.health.gov.au/internet/immunise/publishing.nsf/Content/Handbook10-home
7. Blyth CC, Jacoby P, Effler PV, Kelly H, Smith DW, Robins C, et al., WAIVE Study Team. Effectiveness of trivalent flu vaccine in healthy young children. Pediatrics. 2014;133(5):e1218-25. DOI: 10.1542/peds.2013-3707 PMID: 24753525
8. Kelly H, Jacoby P, Dixon GA, Carcione D, Williams S, Moore HC, et al., WAIVE Study Team. Vaccine Effectiveness Against Laboratory-confirmed Influenza in Healthy Young Children: A Case-Control Study. Pediatr Infect Dis J. 2011;30(2):107-11. DOI: 10.1097/INF.0b013e318201811c PMID: 21079528
9. Dixon GA, Moore HC, Kelly H, Jacoby P, Carcione D, Williams S, et al., WAIVE study team. Lessons from the first year of the WAIVE study investigating the protective effect of influenza vaccine against laboratory-confirmed influenza in hospitalised children aged 6-59 months. Influenza Other Respi Viruses. 2010;4(4):231-4. DOI: 10.1111/j.1750-2659.2010.00141.x PMID: 20629773
10. Jefferson T, Rivetti A, Di Pietrantonj C, Demicheli V, Ferroni E. Vaccines for preventing influenza in healthy children. Cochrane Database Syst Rev. 2012;8(8):CD004879.PMID: 22895945
11. Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12(1):36-44. DOI: 10.1016/S1473-3099(11)70295-X PMID: 22032844
12. Cowling BJ, Chan KH, Feng S, Chan EL, Lo JY, Peiris JS, et al. The effectiveness of influenza vaccination in preventing hospitalizations in children in Hong Kong, 2009-2013. Vaccine. 2014;32(41):5278-84. DOI: 10.1016/j.vaccine.2014.07.084 PMID: 25092636
13. Department of Health, Australian Government. National Notifiable Surveillance System Data; Accessed 24 Sep 2015. Available from: http://www9.health.gov.au/cda/source/cdaindex.cfm
14. Department of Health, Australian Government. Australian Influenza Surveillance Report No 8 -27 September to 10 October 2014: [Accessed 23 Mar 2015]. Available from: http://www.health.gov.au/internet/main/publishing.nsf/Content/ozflu-surveil-no08-14.htm
15. Kelly PM, Kotsimbos T, Reynolds A, Wood-Baker R, Hancox B, Brown SG, et al. FluCAN 2009: initial results from sentinel surveillance for adult influenza and pneumonia in eight Australian hospitals. Med J Aust. 2011;194(4):169-74.PMID: 21401456
16. Greenland S, Thomas DC. On the need for the rare disease assumption in case-control studies. Am J Epidemiol. 1982;116(3):547-53.PMID: 7124721
17. Rodrigues L, Kirkwood BR. Case-control designs in the study of common diseases: updates on the demise of the rare disease assumption and the choice of sampling scheme for controls. Int J Epidemiol. 1990;19(1):205-13. DOI: 10.1093/ije/19.1.205 PMID: 2190942
18. Smith PG, Rodrigues LC, Fine PE. Assessment of the protective efficacy of vaccines against common diseases using casecontrol and cohort studies. Int J Epidemiol. 1984;13(1):87-93. DOI: 10.1093/ije/13.1.87 PMID: 6698708
19. Cheng AC, Brown S, Waterer G, Holmes M, Senenayake S, Friedman ND, et al. Influenza epidemiology, vaccine coverage and vaccine effectiveness in sentinel Australian hospitals in 2012: the Influenza Complications Alert Network (FluCAN). Commun Dis Intell Q Rep. 2013;37(3):E246-52.PMID: 24890961
20. Cheng AC, Holmes M, Irving LB, Brown SG, Waterer GW, Korman TM, et al. Influenza vaccine effectiveness against hospitalisation with confirmed influenza in the 2010-11 seasons: a test-negative observational study. PLoS One. 2013;8(7):e68760. DOI: 10.1371/journal.pone.0068760 PMID: 23874754
21. Naidu L, Chiu C, Habig A, Lowbridge C, Jayasinghe S, Wang H, et al. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2006- 2010. Commun Dis Intell Q Rep. 2013;37: 1-95.PMID:24410428
22. Australian Bureau of Statistics. ABS statistics. Canberra: Australian Government; 2015. [Accessed 24 Sep 2015]. Available from: http://www.abs.gov.au/
23. Jefferson T, Jones M, Doshi P, Spencer EA, Onakpoya I, Heneghan CJ. Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments. BMJ. 2014;348(2):2545. DOI: 10.1136/bmj.g2545 PMID: 24811411
24. Dobson J, Whitley RJ, Pocock S, Monto AS. Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials. Lancet. 2015;385(9979):1729-37. DOI: 10.1016/S0140-6736(14)62449-1 PMID: 25640810
25. Nguyen-Van-Tam JS, Venkatesan S, Muthuri SG, Myles PR. Neuraminidase inhibitors: who, when, where? Clin Microbiol Infect. 2015;21(3):222-5. DOI: 10.1016/j.cmi.2014.11.020 PMID: 25703253
26. Turner N, Pierse N, Bissielo A, Huang Q, Radke S, Baker M, et al., SHIVERS investigation team. Effectiveness of seasonal trivalent inactivated influenza vaccine in preventing influenza hospitalisations and primary care visits in Auckland, New Zealand, in 2013. Euro Surveill. 2014;19(34):20884. DOI: 10.2807/1560-7917.ES2014.19.34.20884 PMID: 25188614
27. Turner N, Pierse N, Bissielo A, Huang QS, Baker MG, Widdowson MA, et al., SHIVERS investigation team. The effectiveness of seasonal trivalent inactivated influenza vaccine in preventing laboratory confirmed influenza hospitalisations in Auckland, New Zealand in 2012. Vaccine. 2014;32(29):3687-93. DOI: 10.1016/j.vaccine.2014.04.013 PMID: 24768730